<?xml version="1.0" encoding="UTF-8"?>
<p>Following the collapse of the Union of Soviet Socialist Republics (USSR) in 1991, the ensuing economic crisis led to poverty and unemployment in the former Soviet republics. Existing social and cultural ties among the former Soviet Union (FSU) countries and visa-free travel across borders facilitated massive movement of migrants in search of employment [
 <xref rid="B1" ref-type="bibr">1</xref>]. High migration rates in the setting of economic destabilization were accompanied by increased rates of injected drug use, facilitating the transmission of blood-borne viruses such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in the region [
 <xref rid="B2" ref-type="bibr">2</xref>, 
 <xref rid="B3" ref-type="bibr">3</xref>]. Due to their geographic location along drug-trafficking routes from Afghanistan, the main hub of opium production and supply for Russia and Europe, there has been increased trafficking and use of injectable drugs in Central Asia [
 <xref rid="B4" ref-type="bibr">4</xref>]. According to the World Health Organization (WHO), in Eastern Europe, 6.8 million people were estimated in 2015 to be positive for antibodies to HCV (3.3% prevalence) and 4.7 million people were living with chronic HCV (2.3% prevalence; 69% viremia rate), while in Central Asia, these figures were 4.5 million (5.4% prevalence) and 1.9 million (2.3% prevalence; 43% viremia rate) people [
 <xref rid="B5" ref-type="bibr">5</xref>]. The number of people living with HIV in Eastern European and Central Asian (EECA) countries, representing the only region in the world with rising HIV incidence, reached 1.6 million by 2016 [
 <xref rid="B6" ref-type="bibr">6</xref>].
</p>
